Abiopharma

🔍 Smith William A II (Executive)

Company: RELIANCE, INC. (RS)

Report Date: 2026-07-28

Detailed Transactions and Holdings:

• Sold 962 shares of Common Stock at $413.9 per share (Direct)
  Date: 2026-07-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,785.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,391 shares of Common Stock at $414.42 per share (Direct)
  Date: 2026-07-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,394.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-28 | Code: H | nature_of_ownership: Held by Trustee of Reliance, Inc. Employee Stock Ownership Plan | shares_owned_after: 417.00

Footnotes:

• F1: The price reported represents the weighted average sale price of the shares disposed of. The actual sale prices ranged from $413.37 to $414.18. The Reporting Person has provided to the Issuer, and hereby undertakes to provide upon request by the U.S. Securities and Exchange Commission staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F2: The price reported represents the weighted average sale price of the shares disposed of. The actual sale prices ranged from $414.39 to $414.50. The Reporting Person has provided to the Issuer, and hereby undertakes to provide upon request by the U.S. Securities and Exchange Commission staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.